These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18094516)

  • 1. Association of lipoprotein-associated phospholipase A2 with coronary calcification among American and Japanese men.
    El-Saed A; Sekikawa A; Zaky RW; Kadowaki T; Takamiya T; Okamura T; Edmundowicz D; Kita Y; Kuller LH; Ueshima H
    J Epidemiol; 2007 Nov; 17(6):179-85. PubMed ID: 18094516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-associated phospholipase A2 and coronary calcification. The Rotterdam Coronary Calcification Study.
    Kardys I; Oei HH; Hofman A; Oudkerk M; Witteman JC
    Atherosclerosis; 2007 Apr; 191(2):377-83. PubMed ID: 16678183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
    Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
    Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the Dallas Heart Study.
    Brilakis ES; Khera A; McGuire DK; See R; Banerjee S; Murphy SA; de Lemos JA
    Atherosclerosis; 2008 Jul; 199(1):110-5. PubMed ID: 18061193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
    Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
    Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection.
    Ross Eckard A; Longenecker CT; Jiang Y; Debanne SM; Labbato D; Storer N; McComsey GA
    HIV Med; 2014 Oct; 15(9):537-46. PubMed ID: 24650269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.
    Garg PK; McClelland RL; Jenny NS; Criqui MH; Greenland P; Rosenson RS; Siscovick DS; Jorgensen N; Cushman M
    Atherosclerosis; 2015 Jul; 241(1):176-82. PubMed ID: 26004387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein-associated phospholipase A2, a novel cardiovascular inflammatory marker, in HIV-infected patients.
    Mangili A; Ahmad R; Wolfert RL; Kuvin J; Polak JF; Karas RH; Wanke CA
    Clin Infect Dis; 2014 Mar; 58(6):893-900. PubMed ID: 24336757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of lipoprotein-associated phospholipase A2 mass and activity with calcified coronary plaque in young adults: the CARDIA study.
    Iribarren C; Gross MD; Darbinian JA; Jacobs DR; Sidney S; Loria CM
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):216-21. PubMed ID: 15499045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher lipoprotein-associated phospholipase A2 levels are associated with coronary atherosclerosis documented by coronary angiography.
    Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Thuboi S; Ogita M; Miyazaki T; Nishino A; Yokoyama K; Kurata T; Yatomi Y; Daida H
    Ann Clin Biochem; 2012 Nov; 49(Pt 6):527-33. PubMed ID: 22933444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
    Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Heiss G; Sharrett AR
    Circulation; 2004 Feb; 109(7):837-42. PubMed ID: 14757686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intima-media thickness of the carotid artery and the distribution of lipoprotein subclasses in men aged 40 to 49 years between whites in the United States and the Japanese in Japan for the ERA JUMP study.
    Sekikawa A; Ueshima H; Sutton-Tyrrell K; Kadowaki T; El-Saed A; Okamura T; Takamiya T; Ueno Y; Evans RW; Nakamura Y; Edmundowicz D; Kashiwagi A; Maegawa H; Kuller LH
    Metabolism; 2008 Feb; 57(2):177-82. PubMed ID: 18191046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Much lower prevalence of coronary calcium detected by electron-beam computed tomography among men aged 40-49 in Japan than in the US, despite a less favorable profile of major risk factors.
    Sekikawa A; Ueshima H; Zaky WR; Kadowaki T; Edmundowicz D; Okamura T; Sutton-Tyrrell K; Nakamura Y; Egawa K; Kanda H; Kashiwagi A; Kita Y; Maegawa H; Mitsunami K; Murata K; Nishio Y; Tamaki S; Ueno Y; Kuller LH
    Int J Epidemiol; 2005 Feb; 34(1):173-9. PubMed ID: 15563587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of aortic calcification in Japanese compared to white and Japanese-American middle-aged men is confounded by the amount of cigarette smoking.
    El-Saed A; Curb JD; Kadowaki T; Okamura T; Sutton-Tyrrell K; Masaki K; Seto TB; Takamiya T; Choo J; Edmundowicz D; Evans RW; Fujiyoshi A; Nakamura Y; Miura K; Shin C; Kuller LH; Ueshima H; Sekikawa A
    Int J Cardiol; 2013 Jul; 167(1):134-9. PubMed ID: 22240754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of coronary artery calcium in Japanese American men and white men in the ERA JUMP study.
    Ahuja V; Masaki K; Vishnu A; Ye L; Wilcox B; Wassel C; Fujiyoshi A; Barinas-Mitchell EJ; Miura K; Ueshima H; Rodriguez BL; Edmundowicz D; Sekikawa A;
    Int J Cardiol; 2017 Feb; 228():672-676. PubMed ID: 27883980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in young patients with acute coronary syndrome in China.
    Huang Y; Wu Y; Yang Y; Li W; Lu J; Hu Y
    Sci Rep; 2017 Nov; 7(1):16092. PubMed ID: 29170433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.
    Tellis CC; Tselepis AD
    Biochim Biophys Acta; 2009 May; 1791(5):327-38. PubMed ID: 19272461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow.
    Ding YD; Pei YQ; Wang R; Yang JX; Zhao YX; Liu XL; Shen H; Ma Q; Zhang S; Ge HL
    BMC Cardiovasc Disord; 2020 May; 20(1):248. PubMed ID: 32460702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome.
    Dohi T; Miyauchi K; Okazaki S; Yokoyama T; Ohkawa R; Nakamura K; Yanagisawa N; Tsuboi S; Ogita M; Yokoyama K; Kurata T; Yatomi Y; Daida H
    Atherosclerosis; 2011 Dec; 219(2):907-12. PubMed ID: 22024276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.